Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
Tags:
FDA, generics, Amgen, Sensipar, Cipla, Aurobindo
Top 5 viewed boards for week ending March 3, 2018
CP Wire
Sun, 03/4/18 - 01:50 pm
Tags:
cafepharma, Daiichi Sankyo, Shire, Allergan, Amgen, Sanofi, sales meeting, layoffs, Esmya, Pfizer, Celgene, M&A
Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble
Fierce Pharma
Thu, 02/22/18 - 11:28 pm
Tags:
migraines, NASH, Amgen, Eli Lilly, Teva Pharmaceutical, Allergan, Gilead Sciences, Novo Nordisk, Intercept Pharma, PBMs
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
Sun, 02/18/18 - 10:16 am
Tags:
cholesterol, PCSK9 inhibitors, Sanofi, Regeneron, Praluent, Amgen, Repatha
3 Tough Questions for Amgen
Motley Fool
Thu, 02/15/18 - 09:37 am
Tags:
Amgen, payers, cash, margins
Amgen still far from performing an important acquisition
GoinPharma
Sun, 02/11/18 - 06:23 pm
Tags:
Amgen, M&A
Amgen Q4 Earnings Results: 2 Things to Hate and 2 Things to Like
Motley Fool
Sun, 02/4/18 - 11:45 am
Tags:
Amgen, earnings
Amgen reports profit below analyst views, but beats expectations on earnings outlook
CNBC
Fri, 02/2/18 - 09:33 am
Tags:
Amgen, earnings
Amgen’s $70B in ‘deal capacity’ post-tax reform puts the spotlight on ‘big things’ in M&A — analyst
Endpoints
Fri, 02/2/18 - 09:31 am
Tags:
Amgen, tax reform, M&A
What to Expect From Amgen, Inc. in 2018
Motley Fool
Sun, 01/21/18 - 10:40 am
Tags:
Amgen, Enbrel, Neulasta, Aranesp, Epogen, Neupogen, Prolia, Repatha, CAR-T
Amgen kicks off 2018 with double the good news for slow-growing Kyprolis
Fierce Pharma
Thu, 01/18/18 - 10:30 pm
Tags:
Amgen, Kyprolis, Multiple Myeloma
Will 2018 Be Amgen Inc.'s Best Year Yet?
Motley Fool
Wed, 01/17/18 - 10:08 am
Tags:
Amgen, Enbrel, Aranesp, Neulasta, Epogen
5 Things Amgen's CEO Just Said That Investors Need to Know
Motley Fool
Wed, 01/10/18 - 10:13 am
Tags:
Amgen, Pharma CEOs, Bob Bradway, Prolia, M&A
2018 Healthcare And Biotech Outlook
Seeking Alpha
Sun, 01/7/18 - 12:41 pm
Tags:
AbbVie, Abbott Labs, Amgen, Allergan, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb
FDA expands use of Amgen's blockbuster drug
Yahoo/Reuters
Fri, 01/5/18 - 05:42 pm
Tags:
FDA, Amgen, Xgeva, Multiple Myeloma
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Fierce Pharma
Fri, 01/5/18 - 10:28 am
Tags:
China, Opdivo, Repatha, Lynparza, drug approvals, Bristol-Myers Squibb, Amgen, AstraZeneca, Eli Lilly, Gilead Sciences
Amgen's Kyprolis improves overall survival in blood cancer patients
Reuters
Tue, 12/12/17 - 10:47 pm
Tags:
Amgen, Kyprolis, Multiple Myeloma
Novartis seeks to revive Neulasta biosim prospects with data showing it matches Amgen’s blockbuster
Fierce Pharma
Fri, 12/8/17 - 10:41 am
Tags:
Novartis, Neulasta, biosimilars, Amgen, Sandoz, FDA
Republican tax bill makes big winners of Amgen, Gilead and other drugmakers
Marketwatch
Wed, 12/6/17 - 09:48 am
Tags:
taxes, Amgen, Gilead Sciences, offshore accounts, Pfizer, Merck
FDA approves heart protection claims for Amgen cholesterol drug
Reuters
Sat, 12/2/17 - 11:17 am
Tags:
FDA, Amgen, cholesterol, Repatha

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.